Loading…
FibroBiologics, Inc. is projected to rise to $1.46 by 2027, a +30% move from its current price of $1.12. FBLG is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.07 | $1.12 | $1.18 | +0.08% |
| May 30 | $1.05 | $1.12 | $1.20 | +0.16% |
| May 31 | $1.03 | $1.12 | $1.22 | +0.24% |
| Jun 1 | $1.02 | $1.12 | $1.24 | +0.33% |
| Jun 2 | $1.01 | $1.12 | $1.26 | +0.41% |
| Jun 3 | $0.9959 | $1.13 | $1.27 | +0.49% |
| Jun 4 | $0.987 | $1.13 | $1.29 | +0.57% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.987 | $1.13 | $1.29 | +0.57% |
| Week 2 | $0.9398 | $1.13 | $1.37 | +1.14% |
| Week 3 | $0.9063 | $1.14 | $1.43 | +1.72% |
| Week 4 | $0.8797 | $1.15 | $1.49 | +2.30% |
| Week 5 | $0.8576 | $1.15 | $1.55 | +2.89% |
| Week 6 | $0.8385 | $1.16 | $1.60 | +3.47% |
| Week 7 | $0.8217 | $1.17 | $1.65 | +4.06% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
FibroBiologics, Inc. is a clinical-stage biotechnology company in the Healthcare sector that develops fibroblast-based therapies for chronic diseases. Its product pipeline includes CYWC628 (completed pre-clinical trial for the treatment of wound healing); CYMS101 (completed Phase 1 trial for the treatment of multiple sclerosis); CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis.
It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers.
FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.
FibroBiologics, Inc. (FBLG) is a healthcare-focused biotechnology company with a current price of $1.05 and a market capitalization of $5.47M. The stock is ranked 5321 by market position.
The stock trades with a 30-day range of $0.7497 to $1.47 and shows a NEUTRAL technical sentiment. RSI14 is 30, while the SMA50 is $2.17 and the SMA200 is $6.48. The current price action sits near key support at $0.99 and resistance at $1.56.
A major floor 41.7% below — a decisive break under it would weaken the trend.
The nearest floor, 11.6% below — buyers have tended to step in here.
The nearest ceiling, 39.3% above — a clean break opens room to run.
A major ceiling 676.8% above — clearing it would confirm fresh momentum.
Key FBLG support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of FBLG market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.07 | Buy | $1.08 | Buy |
| MA 10 | $1.08 | Buy | $1.10 | Buy |
| MA 20 | $1.17 | Sell | $1.23 | Sell |
| MA 50 | $1.98 | Sell | $2.16 | Sell |
| MA 100 | $4.14 | Sell | $3.75 | Sell |
| MA 200 | $6.38 | Sell | $10.05 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 33.77 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | -26.99 | Neutral |
| Williams %R (14) | -48.00 | Info |
| MACD (12,26,9) | 0.08 | Buy |
| ROC (12) | -3.45 | Sell |
| Bollinger %B (20,2) | 0.41 | Neutral |
| Stochastic %K (14) | 52.00 | Neutral |
| TRIX (15) | -2.79 | Sell |
| Awesome (5,34) | -0.22 | Sell |
| Ultimate (7,14,28) | 57.54 | Neutral |
| Momentum (10) | 0.02 | Buy |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 1.07 | Buy |
| ADX (14) | 43.75 | Sell |
| ATR (14) | 0.07 | Info |
30-day technical picture:
- Sentiment: NEUTRAL
- RSI14: 30
- SMA50: $2.17
- SMA200: $6.48
- Support: $0.99
- Resistance: $1.56
- 30-day range: $0.7497 to $1.47
This snapshot shows a stock trading within a tight, low-price window with notable upside resistance above the current price and a defined near-term support, consistent with a cautious stance.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.99 | $1.12 | $1.70 | 0% | Neutral | |
| $1.07 | $1.46 | $2.16 | +30% | Bullish | |
| $0.9463 | $1.37 | $2.15 | +22% | Bullish | |
| $0.7873 | $1.19 | $1.96 | +7% | Neutral | |
| $0.8037 | $1.27 | $2.17 | +14% | Neutral | |
| $0.7013 | $1.16 | $2.04 | +3% | Neutral | |
| $0.8339 | $1.43 | $2.59 | +27% | Bullish | |
| $1.04 | $1.84 | $3.43 | +64% | Bullish | |
| $0.9371 | $1.72 | $3.29 | +54% | Bullish | |
| $0.8294 | $1.58 | $3.08 | +41% | Bullish | |
| $1.03 | $2.30 | $4.90 | +105% | Bullish | |
| $1.37 | $3.05 | $7.01 | +172% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.99 | $1.12 | $1.32 | +0.00% |
| June 2026 | $0.9665 | $1.16 | $1.43 | +3.21% |
| July 2026 | $0.9929 | $1.21 | $1.53 | +4.35% |
| August 2026 | $0.9514 | $1.17 | $1.51 | -2.98% |
| September 2026 | $0.9538 | $1.19 | $1.55 | +1.29% |
| October 2026 | $1.02 | $1.29 | $1.71 | +8.46% |
| November 2026 | $1.03 | $1.30 | $1.75 | +1.41% |
| December 2026 | $0.9815 | $1.25 | $1.70 | -3.98% |
Click any year to see its month-by-month FBLG forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, FBLG is projected to trade between $0.99 and $1.70, averaging $1.12 — a potential gain of 0% from today's $1.12. Price action looks broadly range-bound.
FibroBiologics, Inc.'s 2027 outlook centres on $1.46, within a $1.07 to $2.16 range. That is up +30% on the projected 2026 average. That marks a +30% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, FBLG could reach as high as $2.15, with a base case around $1.37 and support toward $0.9463 — roughly +22% from $1.12. Momentum favours further upside here.
Expect FBLG to range from $0.7873 to $1.96 through 2029. The $1.19 average target implies a +7% move from current prices. That is -13% versus the projected 2028 average. A consolidation phase looks the most probable path here.
The FBLG price prediction for 2030 points to an average of $1.27 (low $0.8037, high $2.17) — a potential gain of +14% on today's $1.12. Price action looks broadly range-bound.
In 2031, FBLG is projected to trade between $0.7013 and $2.04, averaging $1.16 — a potential gain of +3% from today's $1.12. That is -9% versus the projected 2030 average. A consolidation phase looks the most probable path here.
FibroBiologics, Inc.'s 2032 outlook centres on $1.43, within a $0.8339 to $2.59 range. That is up +24% on the projected 2031 average. That marks a +27% change versus current levels. Momentum favours further upside here.
By 2033, FBLG could reach as high as $3.43, with a base case around $1.84 and support toward $1.04 — roughly +64% from $1.12. Buyers look set to stay in control over this stretch.
Expect FBLG to range from $0.9371 to $3.29 through 2034. The $1.72 average target implies a +54% move from current prices. That is -6% versus the projected 2033 average. Momentum favours further upside here.
The FBLG price prediction for 2035 points to an average of $1.58 (low $0.8294, high $3.08) — a potential gain of +41% on today's $1.12. Buyers look set to stay in control over this stretch.
In 2040, FBLG is projected to trade between $1.03 and $4.90, averaging $2.30 — a potential gain of +105% from today's $1.12. That is up +45% on the projected 2035 average. Momentum favours further upside here.
FibroBiologics, Inc.'s 2050 outlook centres on $3.05, within a $1.37 to $7.01 range. That is up +33% on the projected 2040 average. That marks a +172% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in FBLG today (≈ 892.857143 FBLG) could be worth
$2,720.98
+$1,720.98 (+172%) by 2050 · US Dollar
Based on the average projected FBLG price of $3.05 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in FBLGwould be worth at today's price.
$1,000 invested in FBLG on May 27, 2025 (≈ 61.576356 FBLG) would be worth
$68.97
-$931.03 (-93.1%) today · 0.07× · US Dollar
Based on a FBLG entry price of $16.24 vs. today's $1.12.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.05 | $1,066.67 | +6.7% |
| 1 month ago | $1.43 | $783.22 | -21.7% |
| 3 months ago | $5.66 | $197.88 | -80.2% |
| 6 months ago | $5.48 | $204.38 | -79.6% |
| 1 year ago | $16.24 | $68.97 | -93.1% |
| All time (2.3y) ago | $582 | $1.92 | -99.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our FBLG forecast.
Our base-case forecast reaches $2.20 around 2040.
Implied market cap at $2.20: $11.46M
The multi-year forecast outlines a path of gradual, then amplified gains. For 2030, the model projects an average price of $1.20 with a maximum of $2.07 and a minimum of $0.7523, yielding an estimated ROI of 14.6% and a NEUTRAL sentiment. By 2040, the average price rises to $2.14 with a max of $4.62 and a min of $0.9648, delivering a 104.2% ROI and a BULLISH stance.
In 2050, the average is $2.86 with a max of $6.58 and a min of $1.29, corresponding to a 172.3% ROI and a BULLISH outlook.
The forecast shows a shift from NEUTRAL in the earlier years to BULLISH in later years, with notable upside potential in the 2030s through 2050. These figures are estimates and not guarantees. The path is subject to change and should be considered in the context of market volatility, including an annualized volatility of 100%.
Tap a question to reveal the answer.
2030: min $0.7523, avg $1.20, max $2.07; ROI 14.6%; sentiment NEUTRAL.
Forecasts show varying returns: 2026 ROI 0%, 2027 ROI 31.7%, 2028 ROI 22.4%, 2033 ROI 67.5%, and 2050 ROI 172.3%. The 2050 average price is $2.86, and the current price is $1.05, with the 30-day range $0.7497 to $1.47.
Yes. The forecast's higher-price scenarios include a max of $3.30 in 2033, $4.62 in 2040, and $6.58 in 2050.
$0.7497 to $1.47.
Market cap is $5.47M and rank is 5321.
FibroBiologics, Inc. Community Discussion
0Share your FibroBiologics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.